enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Julio Palmaz - Wikipedia

    en.wikipedia.org/wiki/Julio_Palmaz

    With Johnson & Johnson behind it, and with an additional $100 million invested in its development, the Palmaz stent was approved for use in peripheral arteries in 1991, followed by approval for use in coronary arteries in 1994; Johnson & Johnson quickly captured 90 percent of the market for stents and bought the patent outright from Palmaz ...

  3. History of invasive and interventional cardiology - Wikipedia

    en.wikipedia.org/wiki/History_of_invasive_and...

    Stent technology improved rapidly, and in 1989 the Palmaz-Schatz balloon-expandable intracoronary stent was developed. [24] [25] Initial results with the Palmaz-Schatz stents were excellent when compared to balloon angioplasty, with a significantly lower incidence of abrupt closure and peri-procedure heart attack. [26]

  4. Stent - Wikipedia

    en.wikipedia.org/wiki/Stent

    Though several doctors have been credited with the creation of the stent, the first FDA-approved stent in the U.S. was created by Richard Schatz and coworkers. Named the Palmaz-Schatz (Johnson & Johnson), it was developed in 1987. [21] To further reduce the incidence of restenosis, the drug-eluting stent was introduced in 2003. [22]

  5. List of Johnson & Johnson products and services - Wikipedia

    en.wikipedia.org/wiki/List_of_Johnson_&_Johnson...

    This page was last edited on 11 December 2024, at 07:02 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.

  6. America’s Most Admired Lawbreaker - The Huffington Post

    highline.huffingtonpost.com/miracleindustry/...

    By Steven Brill Letter From the Editors Backstage at Johnson & Johnson. On May 20, about 100 stock analysts gathered in the ballroom of the Hyatt Regency Hotel in New Brunswick, New Jersey, to hear good news from top executives at Johnson & Johnson: The company had 10 new drugs in the pipeline that might achieve more than a billion dollars in annual sales.

  7. Guidant - Wikipedia

    en.wikipedia.org/wiki/Guidant

    On January 11, 2006, Johnson & Johnson presented a counteroffer of $23.2 billion, still less than their original 2004 bid, which the Guidant board accepted. The next day, Boston Scientific increased their bid to $25 billion, followed the next day by Johnson & Johnson increasing their bid to $24.2 billion.

  8. Chemical weapons use in Syria must be investigated, says watchdog

    www.aol.com/news/us-sees-assads-fall-chance...

    AMSTERDAM (Reuters) -The head of the chemical weapons watchdog said on Thursday he would ask Syria's new leaders to grant investigators access to the country to continue work identifying ...

  9. Would a government shutdown affect mail delivery? What to know

    www.aol.com/news/government-shutdown-affect-mail...

    With a potential government shutdown looming ahead of the holidays, here's what you need to know if mail services will be impacted by it.